Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study

被引：0
|
作者：
Costa, A [1 ]
Almodovar, T [1 ]
Seada, J [1 ]
Barata, F [1 ]
Teixeira, E [1 ]
Queiroga, H [1 ]
Pires, S [1 ]
机构：
[1] Hosp Pulido Valente, Lisbon, Portugal
来源：
PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE | 2004年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The combination of docetaxel and gemcitabine is an active 1(st) line chemotherapy against NSCLC. This phase II study aimed to assess the efficacy and safety of this combination in patients with stage IIIB/IV NSCLC. Pts were treated with gemcitabine 800 mg/m(2) dl, d8 and docetaxel 85 mg/m(2) d8, q3w. 34 pts were enrolled. PR was observed in 8 pts (25.8%; 95% CI, 10.4%-41.2%), SD in 16 (51.6%) and PD in 7 (22.6%). The median duration of response and the TTP were 8.9 and 5.3 months, while the median survival time was 10.9 months. The 1 and 2-year survival rates were 45% and 18%. Most toxicities were mild and nonhematologic. Neutropenia G3/4 occurred in 6 (17,6%) pts. In conclusion combination therapy with docetaxel and gemcitabine is an effective and well-tolerated (1st) line treatment option in pts with stage IIIB/IV NSCLC.
引用
收藏
页码：117 / 120
页数：4
相关论文
共 50 条
  • [1] First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
    Georgoulias, V
    Androulakis, N
    Dimopoulos, AM
    Kourousis, C
    Kakolyris, S
    Papadakis, E
    Apostolopoulou, F
    Papadimitriou, C
    Vossos, A
    Agelidou, M
    Heras, P
    Tzannes, S
    Vlachonicolis, J
    Mavromanolakis, E
    Hatzidaki, D
    ANNALS OF ONCOLOGY, 1998, 9 (03) : 331 - 334
  • [2] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic nonsmall-cell lung cancer: a multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    LUNG CANCER, 2004, 45 : S79 - S79
  • [3] Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
    Georgoulias, V
    Kouroussis, C
    Androulakis, N
    Kakolyris, S
    Dimopoulos, MA
    Papadakis, E
    Bouros, D
    Apostolopoulou, F
    Papadimitriou, C
    Agelidou, A
    Hatzakis, K
    Kalbakis, K
    Kotsakis, A
    Vardakis, N
    Vlachonicolis, J
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 914 - 920
  • [4] Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer
    Georgoulias, V
    Androulakis, N
    Bouros, D
    Kouroussis, C
    Chatzakis, K
    Papadakis, M
    Apostopoloulou, F
    Georgepoulou, T
    Kotsakis, T
    Souklakos, J
    Hatzidaki, D
    Vlachonikolis, J
    Panagos, G
    LUNG CANCER, 1998, 21 (03) : 213 - 220
  • [5] First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study
    Tibaldi, C.
    Vasile, E.
    Lo Dico, M.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    Falcone, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 176 - 176
  • [6] Randomized multicenter phase II study with docetaxel in combination with either cisplatin or oxaliplatin as first-line treatment in patients with advanced or metastatic non-small cell lung cancer
    Atmaca, A.
    Al-Batran, S.
    Guener, T.
    Pauligk, C.
    Koepke, A.
    Bernhard, H.
    Wenzel, T.
    Banat, A. G.
    Brueck, P.
    Caca, K.
    Prasnikar, N.
    Kullmann, F.
    Jaeger, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
  • [8] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    F Cappuzzo
    S Novello
    F De Marinis
    V Franciosi
    M Maur
    A Ceribelli
    V Lorusso
    F Barbieri
    L Castaldini
    E Crucitta
    L Marini
    S Bartolini
    G V Scagliotti
    L Crinò
    British Journal of Cancer, 2005, 93 : 29 - 34
  • [9] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    Cappuzzo, F
    Novello, S
    De Marinis, F
    Franciosi, V
    Maur, M
    Ceribelli, A
    Lorusso, V
    Barbieri, F
    Castaldini, L
    Crucitta, E
    Marini, L
    Bartolini, S
    Scagliotti, GV
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 29 - 34
  • [10] Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer
    Manegold, Christian
    Pilz, Lothar Richard
    Koschel, Gabriele
    Roemer, Katrin Schott-von
    Mezger, Joerg
    Hruska, Dagmar
    Dornof, Wolfgang
    Gosse, Helga
    Gatzemeier, Ulrich
    CLINICAL LUNG CANCER, 2005, 7 (03) : 208 - 214
12345